The superficial femoral artery (SFA) is a relatively rare location for lower limb aneurysmatic disease. In the literature, this disease is described an association between a relatively high growth rate and/or the rupture of aneurysms and chemotherapeutic agents. We report a case of the rupture of a giant SFA aneurysm in a patient during chemotherapy for acute lymphatic leukemia. 
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CASE REPORT
An 80-year-old male was admitted to Molinette Hospital due to an acute painful pulsatile mass located in the distal portion of his left thigh ( Fig. 1) , referred by the patient and relatives to be in progressive enlargement in the last few months. The patient was affected by refractory anemia with excess blasts in transformation, associated with acute lymphatic leukemia. His past medical history included arterial hypertension and type-2 diabetes mellitus treated with oral hypoglycemic agents; no history of smoking was present.
Preliminary blood tests showed severe thrombocytopenia (17,000 platelets/L) and anemia (hemoglobin blood level, 7.6 g/dL). The patient's blood pressure was 120/80 mmHg, and his heart rate was 100 bpm. Distal pulses were present, and there were no signs of lower limb ischemia. Echo color and these combined effects could cause a rapid aneurysm enlargement. To the best of our knowledge, this is the first case of femoral artery aneurysm rupture likely to be associated with chemotherapy.
